NeoCore Technology Co., Ltd. (4131.TWO)
TWD 31.95
(-10.0%)
TWD 31.95
(-10.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -72.11 Million TWD | -145.0% |
| 2022 | -31.17 Million TWD | -95.23% |
| 2021 | -16.07 Million TWD | 21.91% |
| 2020 | -20.48 Million TWD | -25.75% |
| 2019 | -4.2 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -16.06 Million TWD | 27.38% |
| 2024 Q2 | -17.26 Million TWD | 5.26% |
| 2023 Q2 | -17.68 Million TWD | -85.04% |
| 2023 Q4 | -23.89 Million TWD | -14.06% |
| 2023 Q1 | -9.55 Million TWD | -52.61% |
| 2023 FY | - TWD | -145.0% |
| 2023 Q3 | -20.95 Million TWD | -18.49% |
| 2022 Q3 | -10.64 Million TWD | 0.0% |
| 2022 FY | - TWD | -95.23% |
| 2022 Q4 | -6.26 Million TWD | 41.16% |
| 2021 FY | - TWD | 21.91% |
| 2020 FY | - TWD | -25.75% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -55.945% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 118.322% |
| Level Biotechnology Inc. | 98.7 Million TWD | 173.062% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -61.19% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -185.796% |
| GlycoNex Incorporation | -126.82 Million TWD | 43.139% |
| VBI | -6.97 Million TWD | -934.352% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 49.814% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 430.651% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -306.832% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 30.401% |
| Visgeneer Inc. | 973 Thousand TWD | 7511.614% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 78.757% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 107.701% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 172.233% |
| Neith Corporation | -33.61 Million TWD | -114.564% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 92.724% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -4051.698% |
| Enimmune corporation | -228.96 Million TWD | 68.504% |
| TaiRx, Inc. | -208.64 Million TWD | 65.437% |
| CHO Pharma, Inc. | -277.73 Million TWD | 74.034% |
| EirGenix Inc. | -664.4 Million TWD | 89.146% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 197.579% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 204.298% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 93.269% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 36.241% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 307.001% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -15.678% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -174.202% |
| RBC Bioscience Corporation | 36.54 Million TWD | 297.321% |
| BiOptic Inc. | 65.03 Million TWD | 210.881% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 89.433% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -118.491% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -31.321% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 116.633% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 9.937% |
| NaviFUS Corp. | -55.79 Million TWD | -29.25% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -334.48% |
| Sinew Pharma Inc. | -163.63 Million TWD | 55.928% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -17.26% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 137.481% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 68.186% |
| AP Biosciences Inc | -325.51 Million TWD | 77.846% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 93.097% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -101.18% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 347.563% |
| Intech Biopharm Corporation | -219.58 Million TWD | 67.159% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 89.304% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -60.43% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 55.168% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 111.001% |
| TCI GENE Inc. | 25.98 Million TWD | 377.568% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 34.819% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 74.588% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 50.596% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 620.686% |
| PharmaEngine, Inc. | 347.3 Million TWD | 120.764% |
| Savior Lifetec Corporation | 219.6 Million TWD | 132.839% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 141.871% |
| OBI Pharma, Inc. | -855.08 Million TWD | 91.566% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 22.091% |
| Acepodia, Inc. | -764.51 Million TWD | 90.567% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 84.326% |